Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes
- DOI
- 10.1016/j.tjpad.2026.100691
- Published
- 2026-12
- Container
- The Journal of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tjpad.2026.100691,
title = {Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes},
author = {Yu-Hsin Yen and James Cheng-Chung Wei and Yao-Min Hung and Shih-Yi Lin and Fu-Shun Yen and Heng-Jun Lin and Yu-Han Huang and Der-Yang Cho and Chii-Min Hwu and Chih-Cheng Hsu},
year = {2026},
journal = {The Journal of Prevention of Alzheimer's Disease},
doi = {10.1016/j.tjpad.2026.100691},
url = {https://doi.org/10.1016/j.tjpad.2026.100691}
}RIS
TY - JOUR TI - Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes AU - Yu-Hsin Yen AU - James Cheng-Chung Wei AU - Yao-Min Hung AU - Shih-Yi Lin AU - Fu-Shun Yen AU - Heng-Jun Lin AU - Yu-Han Huang AU - Der-Yang Cho AU - Chii-Min Hwu AU - Chih-Cheng Hsu PY - 2026 JO - The Journal of Prevention of Alzheimer's Disease DO - 10.1016/j.tjpad.2026.100691 UR - https://doi.org/10.1016/j.tjpad.2026.100691 ER -
APA
Yen, Y., Wei, J. C., Hung, Y., Lin, S., Yen, F., Lin, H., Huang, Y., Cho, D., Hwu, C., & Hsu, C. (2026). Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.1016/j.tjpad.2026.100691
Source records
- crossref · retrieved 2026-11-05T19:45:26.883Z